Zep Shareholder Alert – Investors encouraged to contact law firm

Zep Shareholder Alert – National Securities Law Firm Seeks Higher Price for Shareholders in Connection with Acquisition. Encourages Shareholders to Contact Law Firm for More Information

April 8, 2015
New York, New York

Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the acquisition of Zep Inc. (NYSE: “ZEP”) (“Zep” or the “Company”) on behalf of its shareholders. Zep and New Mountain Capital announced that they have entered into a definitive merger agreement under which New Mountain Capital will acquire all outstanding shares of Zep common stock for $20.05 per share in cash.

Our investigation has determined that the offer price of only $20.05 per share unfairly under-values the true going forward inherent value of Zep and that shareholders are not receiving the maximum value for their shares. Indeed, among other things, analysts have projected that Zep’s stock is worth at least $21 per share. In addition, the Company announced today improved financial results for its fiscal second quarter 2015. The investigation further seeks to determine whether senior management of Zep are acting in their own self-interests at the expense of shareholders.

If you are a shareholder of Zep and would like additional information as to how the acquisition may affect your rights as a shareholder, and how you may be eligible to obtain a higher price for your shares, please contact us toll free at 1-800-906-6432 or contact us via our website.

Tripp Levy PLLC represents individual and institutional shareholders in mergers and acquisitions transactions and, along with its affiliate, has recovered billions of dollars for shareholders in securities actions around the globe. Tripp Levy PLLC is affiliated with the law firm Milberg LLP. The National Law Journal has named Milberg one of the “50 Elite Trial Lawyer Firms” and one of the “50 Leading Plaintiff Firms in America.” Attorney advertising. Prior results do not indicate a similar outcome.